Arecor Therapeutics plc (LON:AREC – Get Free Report)’s stock price dropped 1.3% during trading on Tuesday . The stock traded as low as GBX 74 ($0.92) and last traded at GBX 74 ($0.92). Approximately 204 shares traded hands during trading, a decline of 90% from the average daily volume of 2,132 shares. The stock had previously closed at GBX 75 ($0.94).
Arecor Therapeutics Stock Down 1.3 %
The company has a current ratio of 1.37, a quick ratio of 6.24 and a debt-to-equity ratio of 5.51. The firm has a market cap of £27.94 million, a P/E ratio of -264.29 and a beta of -0.18. The stock’s fifty day moving average is GBX 73.68 and its two-hundred day moving average is GBX 82.07.
About Arecor Therapeutics
Arecor Therapeutics plc is a biopharmaceutical company transforming patient care by bringing innovative medicines to market. Through the enhancement of existing medicines using our Arestat™ technology, we are developing a broad portfolio of therapies as part of our proprietary pipeline and through partnerships with leading pharmaceutical and biotech companies.
See Also
- Five stocks we like better than Arecor Therapeutics
- 3 Tickers Leading a Meme Stock Revival
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Conference Calls and Individual Investors
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Upcoming IPO Stock Lockup Period, Explained
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
